| abstract |
Novel antiviral compounds and pharmaceutical compositions comprising one or more antiviral compounds and methods for their synthesis are disclosed herein. Also disclosed herein are methods for improving and/or treating paramyxovirus infection using one or more small molecule compounds. Examples of paramyxovirus infections include infections caused by human respiratory syncytial virus (RSV). |